Login / Signup

Plasma complement C7 as a target in non-small cell lung cancer patients to implement 3P medicine strategies.

Jae Gwang ParkBeom Kyu ChoiYoungjoo LeeEun Jung JangSang Myung WooJun Hwa LeeKyung-Hee KimHeeyoun HwangWonyoung ChoiSe-Hoon LeeByong-Chul You
Published in: The EPMA journal (2021)
The online version contains supplementary material available at 10.1007/s13167-021-00266-x.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • prognostic factors
  • psychometric properties